|
|
Article: Amsterdam Molecular Raises [euro]50M In IPO For Gene Therapies.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
The Dutch company Amsterdam Molecular Therapeutics Holding BV completed a C50 million (US$67 million) initial public offering to fund development of its gene-based therapies for orphan diseases.
Amsterdam-based AMT sold 5 million shares at C10 per share. ABN AMRO Rothschild and Kempen & Co. are underwriting the offering, and have an overallotment option to purchase up to 750,000 additional shares.
The shares, under the symbol "AMT," closed at C10.03 on the Euronext Exchange in Amsterdam in their debut Wednesday. The offering priced at the high range estimated when AMT filed its prospectus June 6. It said then it expected to sell up ...